Methylmercury upregulates RE-1 silencing transcription factor (REST) in SH-SY5Y cells and mouse cerebellum by Guida, Natascia et al.
NeuroToxicology 52 (2016) 89–97
Contents lists available at ScienceDirect
NeuroToxicologyFull Length ArticleMethylmercury upregulates RE-1 silencing transcription factor (REST)
in SH-SY5Y cells and mouse cerebellum
Natascia Guida a, Giusy Laudati b, Serenella Anzilotti a, Rossana Sirabella b,
Ornella Cuomob, Paola Brancaccio b, Marianna Santopaolo c, Mario Galgani d,
Paolo Montuori e, Gianfranco Di Renzo b, Lorella M.T Canzoniero b,f, Luigi Formisano b,f,*
a IRCSS SDN, Naples 80131, Italy
bDivision of Pharmacology, Department of Neuroscience, Reproductive and Dentistry Sciences, School of Medicine, ‘‘Federico II’’ University of Naples, Naples
80131, Italy
cDipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita` degli Studi di Napoli ‘‘Federico II’’ Napoli, 80131, Italy
d Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Napoli, 80131, Italy
eDepartment of Preventive Medical Sciences, University Federico II, Via Pansini 5, 80131 Naples, Italy
fDivision of Pharmacology, Department of Science and Technology, University of Sannio, 82100 Benevento, ItalyA R T I C L E I N F O
Article history:
Received 31 July 2015
Received in revised form 9 November 2015
Accepted 11 November 2015
Available online 21 November 2015
Keywords:
Methylmercury
REST
Acetylation
Cerebellum
A B S T R A C T
Methylmercury (MeHg) is a highly neurotoxic compound that, in adequate doses, can cause damage to
the brain, including developmental defects and in severe cases cell death. The RE-1–silencing
transcription factor (REST) has been found to be involved in the neurotoxic effects of environmental
pollutants such as polychlorinated biphenyls (PCBs). In this study, we investigated the effects of MeHg
treatment on REST expression and its role in MeHg-induced neurotoxicity in neuroblastoma SH-SY5Y
cells. We found that MeHg exposure caused a dose- and time- dependent apoptotic cell death, as
evidenced by the appearance of apoptotic hallmarks including caspase-3 processing and annexin V
uptake. Moreover, MeHg increased REST gene and gene product expression. MeHg-induced apoptotic
cell deathwas completely abolished by REST knockdown. Interestingly,MeHg (1 mM/24 h) increased the
expression of REST Corepressor (Co-REST) and its binding with REST whereas the other REST cofactor
mammalian SIN3 homolog A transcription regulator (mSin3A) was not modiﬁed. In addition, we
demonstrated that the acetylation of histone protein H4 was reduced after MeHg treatment and was
critical for MeHg-induced apoptosis.
Accordingly, the pan-histone deacetylase inhibitor trichostatin-A (TSA) prevented MeHg-induced
histone protein H4 deacetylation, thereby reverting MeHg-induced neurotoxic effect. Male mice
subcutaneously injected with 10 mg/kg of MeHg for 10 days showed an increase in REST expression in
the granule cell layer of the cerebellum together with a decrease in histone H4 acetylation. Collectively,
we demonstrated that methylmercury exposure can cause neurotoxicity by activating REST gene
expression and H4 deacetylation.
 2015 Elsevier Inc. All rights reserved.1. Introduction
The ubiquitous environmental neurotoxin methylmercury
(MeHg) readily crosses the blood-brain barrier, through the L-type
large neutral amino acid transporter, and induces serious neuro-
logical damage (Simmons-Willis et al., 2002). Low concentrations* Corresponding author at: Division of Pharmacology, Department of Science and
Technology, University of Sannio, Via Port’ Arsa 11, 82100 Benevento, Italy.
Tel.: +39 0824305116/0817463315; fax: +39 0824305142.
E-mail address: cformisa@unisannio.it (L. Formisano).
http://dx.doi.org/10.1016/j.neuro.2015.11.007
0161-813X/ 2015 Elsevier Inc. All rights reserved.of mercury are able to induce oxidative stress, cell cytotoxicity and
to increase the secretion of b-amyloid 1–40 and 1–42, which may
lead to neurodegenerative diseases, such as Alzheimer’s and
Parkinson’s diseases (Olivieri et al., 2002). Moreover, an increase
of hypoesthesia, ataxia, dysarthria and impairment of hearing
and visual change (Ninomiya et al., 1995) has been found in the
patients 10 years after the end of methylmercury dispersion from
Minamata, on coast of Shiranui sea, as a consequence of a long-term
exposure study to low doses. Indeed, observational studies of
individuals exposed to high levels of neurotoxin early in life in
Minamata, where methylmercury was discharged in waste water
showed neurological dysfunction such as cerebellar ataxia, visual
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(Eto et al., 2010). The brain regions most susceptible to MeHg-
mediated injury are the brain cortex and the cerebellum (Fahrion
et al., 2012). For the cerebellum, the degeneration seems to occur
particularly in cerebellar granule cells (CGCs) (Fujimura and Usuki,
2014, 2015). Interestingly, in experimental animal studies MeHg
induces degeneration of the cerebellar cortex, leaving Purkinje cells
intact (Fujimura and Usuki, 2014, 2015, Nagashima et al., 1996).
Different molecular targets have been associated with MeHg-
induced neuronal cell death, including the N-methyl-D-aspartate
(NMDA) receptors (Ndountse and Chan, 2008), Ca2+ channels
(Gasso et al., 2001), Rho-associated coiled coil-forming protein
kinase (ROCK) (Fujimura et al., 2011), and, recently, the suppression
of tropomyosin receptor kinase A (TrkA) pathway (Fujimura and
Usuki, 2015).
A new interesting target to investigate in MeHg-induced
toxicity is the repressor element 1 (RE-1)–silencing transcription
factor (REST). Indeed, perturbation in the expression and function
of REST is involved in several neurological disorder such as stroke
(Formisano et al., 2015b, Formisano et al., 2013), epilepsy
(McClelland et al., 2014), Huntington disease (Zuccato et al.,
2003), neuropathic pain (Uchida et al., 2010), and neurotoxicity
induced by the environmental neurotoxicants PCBs (Formisano
et al., 2011, Formisano et al., 2014, Formisano et al., 2015a). It is
well known that REST, by binding to the RE-1 elements, actively
represses a large array of coding and non coding RNAs, such asmiR-
132, all of which have a pivotal role in synaptogenesis, synaptic
plasticity, and structural remodeling (Hwang et al., 2014). Thus, in
brain ischemia REST translocates in the nucleus, thus repressing
some target genes, such as a-amino-3-hydroxy-5-methyl-4-
isoxazole-propionic acid receptor (AMPAR) ‘‘Ca2+ ion gatekeeper’’
subunit GluR2 and sodium-calcium exchanger 1 (NCX1). REST
induces its toxic effect through histone deacetylation (Formisano
et al., 2013, Noh et al., 2012). Indeed, treatment with the pan-
histone deacetylase (HDAC) inhibitor trichostatin-A (TSA) or the
HDAC class I inhibitorMS-275 rescues neurons from REST-induced
cell death (Formisano et al., 2015b, Noh et al., 2012).
Since we hypothesized the involvement of REST in methylmer-
cury-induced neurotoxicity, we examined the effects of MeHg
treatment on REST expression and its role in MeHg-induced
neurotoxicity in neuroblastoma SH-SY5Y cells and in mouse
cerebellum. Our in vitro analyses revealed that REST and histone
H4 protein deacetylation are involved in MeHg-induced neurotox-
icity; consistently, our in vivo experiments indicate that the
subcutaneous administration of MeHg (10 mg/Kg/day) in mice
leads to increased levels of REST protein expression in the
cerebellum, a region highly vulnerable to MeHg-induced neuro-
toxicity.
2. Material and methods
2.1. Drug and chemicals
Methylmercury (II) chloride (MeHg) (cod: 442534 stock
solution 100mM) and trichostatin A (TSA) (cod: T8552 stock
solution 100 mM) both obtained from Sigma–Aldrich (St. Louis,
MO) were dissolved in water with NaHCO3 at 25 mM (Zimmer-
mann et al., 2014), and with dimethyl sulfoxide (DMSO),
respectively. Culture media and sera were purchased from
Invitrogen (Milan, Italy). For in vivo experiments, MeHg was
coniugated with cysteine (Cys) and its reaction was conﬁrmed by
Ellman’s reaction (Zimmermann et al., 2014). All chemicals were
diluted in cell culture medium. In all experiments, the control
group (CTL) was treated with vehicle: water with NaHCO3
(25 nM) for MeHg and DMSO (0.1%) for TSA.2.2. Cell Cultures and siRNA transfections
Human neuroblastoma SH-SY5Y cells (IRCCS Azienda Ospeda-
liera Universitaria San Martino-IST-Instituto Nazionale per la
Ricerca sul Cancro, Genoa, Italy) were grown as previously
described (Formisano et al., 2014). After 24 h of cell seeding,
MeHg at 0.1–3mM was added to Dulbecco’s Modiﬁed Eagle
Medium (DMEM) medium containing 1% fetal bovine serum (FBS)
for 6–36 h. After cell seeding and before MeHg exposure (1 mM/
24 h), cells were pre-treated with TSA (10–50 nM) for 2 h. For REST
synthetic small interfering RNA (siRNA) transfection, cells were
transfected with siRNA against REST (siREST) and negative control
siRNA (siCTL) 24 h before MeHg treatment (1mM/24 h). The
transfection was performed with HiPerFect Transfection Reagent
(Quiagen) in accordance with the manufacturer’s protocol. siREST
(20 nM) was transfected into SH-SY5Y cells as previously reported
(Formisano et al., 2015a). The sequences of siRNA for REST were as
follows: forward 50-GAUGGAGGGUGCCCAGAUATT-30 and reverse
50-UAUCUGGGCACCCUCCAUCTG-30 (NM_005612). For siCTL All
Stars Negative Control siRNA (Qiagen) (cod: 1027280) was used.
siRNA transfection efﬁciency was 60% for SH-SY5Y (data not
shown). Finally, cells were exposed to MeHg (1 mM) for 24 h. They
were then plated in 24-multiwell plates at a density of 2 105 for
the MTT assay, annexin V- and propidium iodide staining, and in
100 mm well plates at a density of 10  105 for quantitative
reverse-transcription polymerase chain reaction (RT-PCR), West-
ern blot, and immunoprecipitation analyses.
2.3. Determination of cell viability
Cell viability was evaluated by MTT assay (Guida et al., 2014)
under various experimental conditions: (1) cells were treated with
MeHg at increasing concentrations of 0.1–3 mM for 24 h; (2) cells
were treated with MeHg at 1mM for 6–36 h; (3) cells were
transfected with siREST and siCTL or pre-treated with TSA (10–
50 nM) for 2 h, and, after 24 h, they further incubated with 1 mM
MeHg for 24 h.
2.4. Annexin V/Propidium iodide staining
Experiments were performed as previously reported (Formi-
sano et al., 2015a, Guida et al., 2014). Brieﬂy, cells were treated
with MeHg either at 0.1–3mM for 24 h or at 1mM for 6–36 h. In
other experiments, cells were transfected with siREST and siCTL
and, 24 h later, treated with 1mM MeHg for 24 h. After MeHg
exposure, theywerewashedwith ice-cold PBS and collected on ice.
Apoptosis and necrosis were evaluated by staining the cells with
annexin V and propidium iodide (PI), respectively, for 30 min in
ice-cold PBS containing both dyes and after that, they were
suspended for deposition on slides. A negative sample was
acquired for control staining. The analysis was performed on
10 ﬁelds for each experimental condition. In addition, the cells
were at a concentration of 150,000/ml, and the analyses were
performed on 35,000 cells for each experimental condition.
2.5. Quantitative reverse transcription polymerase chain reaction
(qRT-PCR) analysis
Total RNA extraction and cDNA synthesis from SH-SY5Y cells
and quantitative real-time PCR were performed as previously
reported (Formisano et al., 2015a, Guida et al., 2014). Sampleswere
ampliﬁed simultaneously in quadruplicate in a one-assay run, and
the threshold cycle (cT) value for each experimental group was
determined. Normalization of the data was performed using
ribosomal protein L19 (L19). To evaluate differences in mRNA
content between groups, normalized values were entered into the
N. Guida et al. / NeuroToxicology 52 (2016) 89–97 91formula 2DDct. The oligonucleotide sequences for REST and L19
were as follows: The oligonucleotide sequences were for REST: 50-
TCACATGGAGCCAATTTCCA-30 and 50-TTTCCTTTGGCAGTGGTGGT-
30 (XM_011534402.1); and for L19:50-CTAGTGTCCTCCGCTGTGG-30
and 50- AAGGTGTTTTTCCGGCATC-30 (NM_032019.5) (Formisano
et al., 2011, Guida et al., 2014).
2.6. Western Blot analysis and Immunoprecipitation
Total protein extracts from cells and brain tissues (mice
cerebellum and cortex) were performed as previously reported
(Formisano et al., 2013). In brief, 100mg of proteins was used to
detect REST, CoREST, and mSIN3A, whereas 50 mg was used for
histone H4 acetylation. Proteins from cells and tissues were
separated on an 8% SDS-PAGE for REST, CoREST, and mSIN3A, and
on 15% SDS-PAGE for histone H4 acetylation. After that, running
proteins were electroblotted on nitrocellulose (Ge Healthcare,
Milan, IT). Immunoprecipitation of REST inMeHg-treated cells was
performed as previously described (Formisano et al., 2015a). In
brief, cell lysates (1 mg) were immunoprecipitated overnight at
4 8C using REST antibody (3mg) and IgG as a negative control.
Protein A/G-agarose beads (25ml) (sc-2003 Santa Cruz Biotech-
nology) were used to precipitate the bound protein. The
precipitated sampleswere then subjected toWestern blot analysis.
The antibodies used were: anti-calpain (sc-30064, Santa Cruz
Biotechnology, 1:500), anti-CoREST (07-455, Millipore, 1:1000),
anti-histone H4 acetylated (05-858, Millipore, 1:1000), mSin3A
(sc-994, Santa Cruz Biotechnology, 1:1000), anti-caspase-3 (sc-
7272, Santa Cruz Biotechnology, 1:500), anti-REST (07-579,
Millipore, 1:1000) and anti-Tubulin (T5168, Sigma-Aldrich,
1:10000) (Guida et al., 2014).
2.7. In vivo studies
2.7.1. Experimental groups
Adult male mice C57/BL6 (90 days old, weight 50 g) (Charles
River) were housed under diurnal lighting conditions (12 h
darkness/light). Experiments were performed according to the
international guidelines for care and use of experimental animals
of the European Community Council directive (86/609/EEC). All
experiments were approved by the Institutional Animal Care and
Use Committee of ‘‘Federico II’’ University of Naples, IT.
2.7.2. Immunohistochemistry (IHS)
MeHg-Cys complex (10 mg/Kg) was dissolved in water with
NaHCO3 at 25 mM and was subcutaneously administered to mice
(2 ml/Kg) once a day for 10 days (Zimmermann et al., 2014).
Animals were divided into two groups of 5 animals: one group, the
control (CTL), receivedwaterwith NaHCO3 at 25 mMand the other
group, MeHg, received the MeHg-Cys complex. After 10 days, both
animal groups were anesthetized intraperitoneally with chloral
hydrate (300 mg/kg) and a transcardiac perfusion was made with
4% (wt/vol) paraformaldehyde (PFA) in phosphate buffer (PBS).
Serial 10-mm-thick sections were cut in a cryostat and incubated
overnight in anti-REST and anti-H4 acetyl antibodies, diluted in
PBS 2% bovine serum albumin (BSA), and 0.1% Triton X-100.
Afterward, the slices were incubated in a mixture of ﬂuorescent-
labeled secondary antibodies (Alexa 488 or – Alexa 568-
conjugated IgG, 1:200; Molecular Probes, Eugene, OR). Images
were observed with a Zeiss LSM 510 META Laser-Scanning
Confocal Microscope.
2.8. Statistical analysis
Data are expressed as the mean  S.E.M. Statistical comparisons
between the experimental groups were performed using one-wayanalysis of variance followed by the Newman-Keuls test. P < 0.05was
considered statistically signiﬁcant.
3. Results
3.1. MeHg exposure induces apoptotic cell death by increasing REST
expression in SH-SY5Y cells
When SH-SY5Y cells were exposed to different concentrations
of MeHg (0.1–3mM) for 24 h, a dose-related reduction of cell
viability was detected by theMTT assay (Fig. 1A). Furthermore, cell
death was evaluated with FITC-conjugated annexin V, a marker of
apoptosis (Martin et al., 1995) and with propidum iodide (PI), a
marker of necrosis (Bal-Price and Brown, 2000); it was ﬁnally
analyzed with a TaliTM Image Cytometer. Following 24 h of MeHg
treatment at 0.1–3mM, cells were signiﬁcantly positive for
annexin V, but not for PI (Fig. 1B and C). Notably, incubation (6-
36 h) with MeHg at 1 mM induced a time-dependent decrease in
cell viability and an increase in annexin V-positive cells. However,
it did not modify the number of PI-positive cells (Fig. 1 E-G).
Since 1mM MeHg treatment for 24 h damaged approximately
50% of cells, this concentration and this time point were chosen for
our experiments. Interestingly, appearance of active Caspase
3 with MeHg exposure was seen, as opposed to control cells
(Fig. 1D); however, the necrotic marker calpain was unaffected
(Fig. 1H). Regarding the effect of MeHg exposure on REST
expression, MeHg (1mM) strongly increased REST mRNA and
protein expression (Fig. 2A and B).
Next the role of REST in MeHg-induced cell death was
investigated. To this aim, REST was knocked down by speciﬁc
siRNA transfection (siREST). As shown in Fig. 2C, siREST
signiﬁcantly reduced REST expression by 65% compared to siCTL.
Importantly, REST knockdown reverted not only MeHg-induced
cleavage of caspase-3 (Fig. 2D), but also MeHg toxicity, as revealed
by MTT assay and by annexin V uptake (Fig. 2E and F). However, it
had no effect on PI staining (data not shown).
3.2. MeHg induces the formation of REST/Co-REST complex in SH-
SY5Y cells
REST-dependent gene silencing requires the action of tran-
scriptional co-repressors, two of which are mSIN3A and CoREST
(Levenson and Sweatt, 2005). As shown in Fig. 2A–C, MeHg (1mM/
24 h) increased the expression of Co-REST, but not of mSIN3A,
while simultaneously reducing histone H4 acetylation. Next, total
proteins from cells treated with MeHg were immunoprecipitated
with REST antibody and the immunoprecipitate was immuno-
blotted with antibodies for CoREST or mSin3A. After 24 h of
treatment with MeHg (1mM), REST interacted with CoREST, but
not with mSIN3A, whereas no interaction was detected in the
preimmune (PI) group (Fig. 3D and E).
3.3. TSA prevents MeHg-induced cell death by blocking histone
protein H4 deacetylation
It is well known that REST exerts its neurotoxic effect by
epigenetic mechanisms, such as histone deacetylation (Kazantsev
and Thompson, 2008). To this aim, the cells were pre-treated with
the pan-histone HDAC inhibitor TSA at 10, 25, and 50 nM. Not only
did TSA cause a remarkable dose-dependent protective effect
against MeHg-induced cell death (1mM/24 h), as revealed by MTT
(Fig. 1A), but it also counteracted MeHg-induced cleavage of
caspase-3 (Fig. 4D). Furthermore, Western Blot experiments
showed that whereas MeHg decreased histone H4 acetylation,
TSA blocked this reduction (Fig. 4 E).
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Fig. 1. Effect of MeHg on SH-SY5Y cell survival.
(A–C) Effect of 24 h of MeHg (0.1, 0.5, 1, and 3mM) exposure on mitochondrial activity (MTT), necrosis (PI uptake) and apoptosis (Annexin V uptake). Bars represent
mean  S.E.M. obtained from four independent experimental sessions. *P < 0.05 vs. CTL and 0.1 mM, **P < 0.05 vs. CTL,0.1 and 0.5 mM; ***P < 0.05 vs. all. (E-G) Effect of 1 mMMeHg
exposure on MTT, necrosis (PI uptake) and apoptosis (Annexin V uptake) and at 6, 12, 24 and 36 h. Bars represent mean  S.E.M. obtained from four independent experimental
sessions. *P < 0.05 vs. CTL and 6 h, **P < 0.05 vs. CTL, 6 h and 12 h; ***P < 0.05 vs. (D, H) Western blots of pro-caspase-3, cleaved caspase-3, and calpain protein levels in CTL after
24 h of MeHg (1 mM). Graphs show the quantiﬁcation of the ratio of cleaved caspase-3 or calpain to tubulin. Bars represent mean  S.E.M. obtained from three independent
experiments. *P < 0.05 vs CTL, and N.D. not detectable.
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mouse cerebellum brain
In vivomodels ofMeHgneurotoxicitywere investigated to further
validate our in vitro results. Accordingly, REST and histone H4
acetylation expressionwas evaluated in the cortex and cerebellumof
mice subcutaneously-injected with MeHg (10 mg/Kg) for 10 days.Importantly, a MeHg-Cys complex was administered to raise MeHg
accumulation in the brain (Roos et al., 2011). The time point and the
dose of exposure used in this study were the same as those already
known to induce signiﬁcantmotor impairments and accumulation in
the brain, especially in the cerebellum (Zimmermann et al., 2014).
Consistently,weobserved severe locomotor deﬁcits inMeHg-treated
mice similar to those already described (Zimmermann et al., 2014)
[(Fig._2)TD$FIG]
Fig. 2. Effect of MeHg on the levels of REST mRNA and protein expression and of siREST on MeHg-induced apoptotic cell death.
(A,B) qRT-PCR and representativeWestern blot of REST and protein treated for 24 h withMeHg (1 mM) or under control conditions (CTL). Graphs show quantiﬁcation of ratio
of REST to tubulin for Western Blot experiments and of REST to L19 for qRT-PCR experiments. Bars represent mean  S.E.M. obtained from three independent experiments for
Western Blot and four independent experiments for qRT-PCR. *P < 0.05 vs CTL. (C) Representative Western blot and quantiﬁcation of REST protein expression in SH-SY5Y cells
treated for 24 h with MeHg 1 mM and transfected with siCTL and siREST in. Graphs show quantiﬁcation of the ratio of REST to tubulin. Bars represent mean  S.E.M. obtained from
three independent experiments. *P < 0.05 vs siCTL. (D) RepresentativeWestern blots of pro-caspase-3, cleaved caspase-3, and tubulin levels in CTL or after a 24 h exposure to 1 mM
MeHg alone or after siREST transfection. Graphs show quantiﬁcation of the ratio of cleaved caspase-3 to tubulin. Bars represent mean  S.E.M. obtained from four independent
experimental sessions. *P < 0.05 vs CTL **P < 0.05 vs MeHg 1 mM/24 h and N.D. not detectable. (E,F) Effect of a 24-h exposure to 1 mMMeHg alone or after siREST transfection on
MTT and apoptosis (Annexin V uptake) Bars represent mean  S.E.M. obtained from four independent experimental sessions. *P < 0.05 vs. CTL and **P < 0.05 vs. 1 mM MeHg.
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decrease in acetylation of histone protein H4 were detected in the
cerebellum (Fig. 5A,B), but not in the cortex (Fig. 5C,D) of the MeHg-
treated animals, compared with the vehicle-treated group (CTL).
The relationship between REST and acetylated histone H4
expression in the cerebellum of mice treated with MeHg was
further explored by performing IHS analysis by confocal micros-
copy. REST was basally expressed in the granular layer (GL), in
Purkinje cells (PC), and in the molecular layer (ML), whereas
acetylated histone H4 was highly expressed in GL (Fig. 5E,F) but
dimly expressed in PC and ML (Fig. 5G,H). Following 10 days of
MeHg administration, REST expression strongly increased in GL, as
evidenced by the intense REST immunosignal in the cells of this
region (Fig. 5I, L). By contrast, H4 acetylation immunosignal
decreased in the same region (Fig. 5M, N). These results validate
our in vitro ﬁndings and suggest that environmental exposure to
MeHg increases REST expression and deacetylation of histone H4
in the cerebellum granular cell layer.
4. Discussion
In the present study we showed that MeHg induces a dose- and
time-dependent reduction in cell viability in SH-SY5Y cells.
Interestingly, MeHg-induced reduction of cell viability was
accompanied by an increase in cleaved caspase-3 and in annexin
V uptake, but not in calpain and in PI uptake. These ﬁndings
suggest that cell death is due to the activation of an apoptotic but
not of a necrotic pathway. In addition, whereas MeHg induced an
increase in RESTmRNA and protein expression, siRNA against RESTprevented MeHg-induced apoptotic cell death. To our knowledge,
this is the ﬁrst evidence showing that REST is involved in the
neurodetrimental effects of MeHg. This evidence is in accordance
with the known pro-death role played by REST in brain ischemia,
where it increases in the nuclei of CA1 hippocampal neurons
(Formisano et al., 2007, Kaneko et al., 2014, Noh et al., 2012) and in
the cortex (Formisano et al., 2015b, Formisano et al., 2013).
Likewise, REST also seems to be involved in the toxic effect exerted
by other environmental neurotoxins like PCBs. Indeed, evidence of
REST involvement in PCB neurotoxicity is that whereas its mRNA
levels and protein expression are induced after PCB exposure, REST
knockdown blocks A1254 PCB mixture-induced cell death in SH-
SY5Y cells and cortical neurons (Formisano et al., 2011, Formisano
et al., 2014, Formisano et al., 2015b).
Although REST is fully involved in both PCBs and MeHg toxic
effects, the mechanisms whereby it actually contributes to
neurotoxicity following exposure to both toxicants do seem to
differ. For instance, during A1254 exposure, REST induces necrotic
cell death (Formisano et al., 2015a). Instead, in this study we found
that after MeHg exposure REST knockdown reverted annexin V
uptake and cleavage of caspase 3, a ﬁnding triggered after exposure
to MeHg, demonstrating that this toxicant induces apoptosis by
increasing REST expression. These results are in accordance with
other authors showing that MeHg determines cell death by
activating an apoptotic mechanism (Fujimura and Usuki, 2015,
Ndountse and Chan, 2008).
It is well known that REST recruits mSin3A at the N-terminal
(Huang et al., 1999) and CoREST at the C-terminal (Ballas and
Mandel, 2005). In turn, CoREST recruits the histone deacetylase
[(Fig._3)TD$FIG]
Fig. 3. MeHg elicits REST protein interaction with its cofactor CoREST, but not with mSIN3A, thereby increasing histone H4 deacetylation in SH-SY5Y cells.
(A–C) Representative Western blots of CoREST, mSIN3A, and histone H4 acetylation protein levels in CTL and after 24 h of 1 mM MeHg treatment. Graphs show the
quantiﬁcation of the ratio of CoREST, mSIN3A, and histone H4 acetylation to tubulin. Bars represent mean  S.E.M. obtained from four independent experimental sessions.
*P < 0.05 vs. CTL. (D,E) Representative Western blot showing immunoprecipitation between REST and CoREST and between REST and mSIN3A after 24 h of 1 mMMeHg treatment.
IgG was used as a negative control.
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genes, determining their repression. Intriguingly, we found that
MeHg upregulated CoREST, but not mSin3A, thereby causing a
reduction in histone H4 acetylation. Consistently, when we pre-
treated cells with the HDAC inhibitor TSA, MeHg-induced H4
deacetylation was signiﬁcantly blocked, thereby reverting the
neurotoxicity of MeHg and the cleavage of caspase 3. Since
deacetylation of both H3 and H4 histones is used asmarker of REST
target gene transcriptional repression (Calderone et al., 2003b,
Formisano et al., 2007, Noh et al., 2012), we could hypothesize that
also histone H3 acetylation is reduced after MeHg treatment. In
fact, it has been shown that in cells exposed to other environmen-
tal toxicants, like PCBs, REST caused cell death by inducing H3 and
H4 histone deacetylation and TSA, by reverting A1254-induced H3
and H4 deacetylation, reduced cell death (Formisano et al., 2011).
Furthermore, these results suggest that the REST/CoREST/HDAC
pathway—also involved in brain ischemia (Noh et al., 2012)—plays
a key role in the mechanisms involved in MeHg-induced
neurotoxic effects. Furthermore, since CoREST mediates primarily
long-term silencing of target genes, whereas mSin3A mediates
dynamic and reversible gene repression (Ballas et al., 2005, Lunyak
et al., 2002), we speculate that MeHg, by inducing REST-CoREST
interaction, determines a long term silencing of neuroprotective
REST target genes, such as NCX1 (Formisano et al., 2013), GriA2
(Calderone et al., 2003a), and Synapsin-1 (Formisano et al., 2011).
Regarding the MeHg concentrations, it should be underlined that
we used the same MeHg doses as those used by other authors in
the same cell line, (Ndountse and Chan, 2008, Toyama et al., 2010),
i.e., with an IC50 approximately of 0.5 and 1mM.
The most meaningful result of this paper is that MeHg-induced
REST increase caused an apoptotic cell death; whereas it waspreviously reported that the REST increase induced by exposure to
other environmental toxicants determined a necrotic cell death in
SH-SY5Y cells (Formisano et al., 2011, Formisano et al., 2014,
Formisano et al., 2015a, Guida et al., 2015). This discrepancy in the
kind of REST-induced cell death could be due to the difference in
REST cofactors CoREST and mSIN3A recruitment. Indeed, MeHg
induced the recruitment of CoREST only, whereas PCB exposure
induced the recruitment of both cofactors CoREST andmSin3A. The
results of the present study are in accordancewith Noh et al., 2012,
where global brain ischemia, that is known to determine apoptotic
cell death in CA1 neurons (Abe et al., 1995, Jover-Mengual et al.,
2010, Ni et al., 1998), increases REST and CoREST, but not mSin3A
(Noh et al., 2012).
Given that the cerebellum is the best-characterized target of
MeHg toxicity both in humans and rodents (Eto et al., 2010;
Nagashima, 1997), we examined REST expression in the cortex and
cerebellum of mice treated with MeHg.
As regards the dose of MeHg used in our in vivo experiments
(10 mg/Kg/day s.c.), it should be considered that the World Health
Organization (WHO) and Environmental Protection Agency (EPA)
reference dose for hair Hg is now less than 2 ppm, that is 1.8 to
1.2 ppm, respectively, which corresponds to 4,5 and 3 mg/70 kg
(0.063 and 0.043 mg/Kg), respectively. Thus, the dose of MeHg
used in thiswork can be considered quite high referring to humans.
However, the dose of 10 mg/Kg ofMeHg is comparable to that used
in rodent studies on the effects ofMeHg on Central nervous System
(CNS). In fact, it has been shown that this dose is able to elicit a
neurological phenotype in adult mice (Dietrich et al., 2005, Farina
et al., 2011, Zimmermann et al., 2014). In addition, s.c. injection of
10 mg/Kg of MeHg has been used to demonstrate that L-Met
enhances cerebellar deposition of Hg in mice exposed to the
[(Fig._4)TD$FIG]
Fig. 4. Effect of pan HDAC inhibitor TSA on MeHg-induced apoptosis in SH-SY5Y cells.
(A) Effect of 24 h MeHg (1mM) exposure alone or after pretreatment with TSA on MTT at 10, 25 and 50 nM. Bars represent mean  S.E.M. obtained from four independent
experimental sessions. *P < 0.05 vs. CTL 1, **P < 0.05 vs. MeHg (1 mM) and MeHg (1 mM) + TSA (10 nM); ***P < 0.05 vs. all. (B,C) Representative Western blots of pro-caspase-3,
cleaved caspase-3, and tubulin levels in CTL or after a 24 h exposure to 1 mMMeHg, alone or after 2 h pretreatment with TSA (50 nM). Graphs show the quantiﬁcation of the ratio of
cleaved caspase-3 or H4 to tubulin. Bars represent mean  S.E.M. obtained from three independent experimental sessions. *P < 0.05 vs. CTL; **P < 0.05 vs. 1 mM MeHg; N.D. not
detectable.
N. Guida et al. / NeuroToxicology 52 (2016) 89–97 95toxicant, and that this higher depositionmay be responsible for the
greater motor impairment observed in mice simultaneously
exposed to MeHg and L-Met (Zimmermann et al., 2014).
In this study we found that MeHg treatment (10 mg/kg)
increased REST protein expression and decreased histone H4
acetylation in the cerebellum, but not in the cortex. Moreover, IHS
analysis revealed that REST was basally expressed in the granular
and molecular cell layers, whereas it was very low in the Purkinje
cells. The increase in REST and the decrease in histone H4
acetylation occurred in the regions of the cerebellum that are most
vulnerable to MeHg intoxication. Consistently, studies show thatMeHg induces speciﬁc degeneration of the granule cell layers but
not of Purkinje cells (Nagashima et al., 1996).
Collectively, these ﬁndings document that MeHg induces
apoptotic cell death by increasing REST expression in SH-SY5Y
cells. REST, in turn, interacts with CoREST, which by recruiting
HDACs on the REST target genes promoter, determines a
subsequent decrease in histone H4 acetylation. Equally revealing
is having evidenced for the ﬁrst time that MeHg increases REST
expression speciﬁcally in mice cerebellum granular neurons—
thereby making REST a possible new molecular target in the
pathogenesis of cerebellar disorders due to MeHg intoxication.
[(Fig._5)TD$FIG]
Fig. 5. Effect of MeHg on REST and H4 histone acetylation expression in mouse cerebellum
(A–D) Representative Western Blots of REST and acetylated histone H4 and tubulin in control mice (CTL) and in mice subcutaneously-injected with MeHg (10 mg/Kg) once a
day for 10 days. Graphs show quantiﬁcation of the ratio of REST and acetylated histone H4 to tubulin in cerebellum (A,B) and cortex (C,D). Bars represent mean  S.E.M.
obtained from four independent experimental sessions. *P < 0.05 vs. CTL. E-N) Fluorescence images showing REST (red) and H4 histone acetylation (green) immunosignals in
cerebellar cortical layers of mice receiving control vehicle (CTL) (E–H) or MeHg (10 mg/Kg) (I–N) for 10 days. (F, H) Higher magniﬁcation of the frame depicted in E and G displaying
REST and H4 histone acetylation immunoreactivity in control group (CTL). (L,N) Higher magniﬁcation of the frame depicted in I and M displaying REST and H4 histone acetylation
immunoreactivity in MeHg-treated mice. Scale bars in E, G, I and, M is 200 mm; in F, H, L and N 50 mm. Abbreviations: ML, molecular layer, PC, Purkinje cells and GL, granular layer.
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